Kantarjian HM - Search Results

1

Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.

Amin HM, Yang Y, Shen Y, Estey EH, Giles FJ, Pierce SA, Kantarjian HM, O'Brien SM, Jilani I, Albitar M. Amin HM, et al. Among authors: kantarjian hm. Leukemia. 2005 Sep;19(9):1567-72. doi: 10.1038/sj.leu.2403876. Leukemia. 2005. PMID: 16049515

2

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, et al. Estey EH, et al. Among authors: kantarjian hm. Blood. 1992 Feb 15;79(4):882-7. Blood. 1992. PMID: 1346577 Free article.

3

2-Chlorodeoxyadenosine in the treatment of multiple myeloma.

Dimopoulos MA, Kantarjian HM, Estey EH, Alexanian R. Dimopoulos MA, et al. Among authors: kantarjian hm. Blood. 1992 Sep 15;80(6):1626. Blood. 1992. PMID: 1355673 Free article. No abstract available.

4

Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.

Kantarjian HM, Smith T, Estey E, Polyzos A, O'Brien S, Pierce S, Beran M, Feldman E, Keating MJ. Kantarjian HM, et al. Am J Med. 1992 Dec;93(6):599-604. doi: 10.1016/0002-9343(92)90191-d. Am J Med. 1992. PMID: 1466355

5

Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.

Kantarjian HM, Keating MJ, Estey EH, O'Brien S, Pierce S, Beran M, Koller C, Feldman E, Talpaz M. Kantarjian HM, et al. J Clin Oncol. 1992 May;10(5):772-8. doi: 10.1200/JCO.1992.10.5.772. J Clin Oncol. 1992. PMID: 1569449

6

Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.

Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, Kantarjian HM, Trujillo JM. Freireich EJ, et al. Among authors: kantarjian hm. Leukemia. 1992 Jun;6(6):500-6. Leukemia. 1992. PMID: 1602788

7

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia.

Kantarjian HM, Estey EH, O'Brien S, Anaissie E, Beran M, Rios MB, Keating MJ, Gutterman J. Kantarjian HM, et al. Blood. 1992 Feb 15;79(4):876-81. Blood. 1992. PMID: 1737098 Free article.

8

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.

Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A. Kantarjian HM, et al. J Clin Oncol. 1992 Mar;10(3):398-405. doi: 10.1200/JCO.1992.10.3.398. J Clin Oncol. 1992. PMID: 1740679

9

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Keating MJ, Estey EH, O'Brien S, Beran M, McCredie KB, Gutterman J, Freireich EJ. Kantarjian HM, et al. Cancer. 1991 Sep 15;68(6):1201-7. doi: 10.1002/1097-0142(19910915)68:6<1201::aid-cncr2820680604>3.0.co;2-1. Cancer. 1991. PMID: 1873771

10

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.

Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R. Kantarjian HM, et al. Blood. 1991 Nov 1;78(9):2411-8. Blood. 1991. PMID: 1932753 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,039 results

Search Page

Filters